ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Sectoral-PharmaRank #28
4/5
NAV (2026-08-19)
₹43.2
AUM
₹6,802.61 Cr
Exp. Ratio: 2.08%
RISK LEVEL
Very High
Returns & Performance
1 Year7.06%7.59% vs cat avgRank #27
3 Year21.99%0.97% vs cat avgRank #4
5 Year15.45%1.33% vs cat avgRank #2
Since Launch19.78%2.63% vs cat avg
Fund vs Category Average
1Y
7.06%-7.59%
3Y
21.99%+0.97%
5Y
15.45%+1.33%
Pros & Cons
Pros
✔Strong 3Y track record vs category
✔Above category avg 5Y returns
✔No lock-in period
✔Outperforms category avg since launch
Cons
✖1Y returns trail category average
✖Higher expense ratio (2.08%)
✖1Y category rank outside top 15 (#27)
✖Overall rank #28 in category
ISININF109KC1GE9
NAV₹43.2
NAV Date2026-08-19
AUM₹6,802.61 Cr
Expense Ratio2.08%
RiskVery High
Rating4 / 5
Min SIP Amount₹100
Max SIP Amount₹999999999
Min Additional Inv.₹1000
SIP AllowedYes
Plan TypeRegular
Plan OptionGrowth
Is NFONo
Fund House Incorp.1993-10-12
INVESTMENT OBJECTIVE
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Exit Load1.00%
Stamp duty on investment0.005% (from July 1st, 2020)
Tax implicationsIf you redeem within one year, your returns will be taxed at 20%. For redemptions after one year, returns exceeding ₹1.25 lakh in a financial year will be taxed at 12.5%.
Sharmila D'Silva
Ms. D'Silva is CA and BAF
She joined ICICI Prudential AMC Limited in September 2016.
